BIOMAT Database Logo BIOMAT Database Logo

Angiotensin converting enzyme inhibition in renovascular hypertension: failure of the stenotic kidney. 1984

M A Schalekamp, and G J Wenting

UI MeSH Term Description Entries
D006978 Hypertension, Renovascular Hypertension due to RENAL ARTERY OBSTRUCTION or compression. Hypertension, Goldblatt,Goldblatt Syndrome,Goldblatt Hypertension,Renovascular Hypertension,Syndrome, Goldblatt
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D012078 Renal Artery Obstruction Narrowing or occlusion of the RENAL ARTERY or arteries. It is due usually to ATHEROSCLEROSIS; FIBROMUSCULAR DYSPLASIA; THROMBOSIS; EMBOLISM, or external pressure. The reduced renal perfusion can lead to renovascular hypertension (HYPERTENSION, RENOVASCULAR). Renal Artery Stenosis,Obstruction, Renal Artery,Obstructions, Renal Artery,Renal Artery Obstructions,Renal Artery Stenoses,Stenoses, Renal Artery,Stenosis, Renal Artery
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000806 Angiotensin-Converting Enzyme Inhibitors A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. ACE Inhibitor,ACE Inhibitors,Angiotensin Converting Enzyme Inhibitor,Angiotensin I-Converting Enzyme Inhibitor,Angiotensin-Converting Enzyme Inhibitor,Kininase II Inhibitor,Kininase II Inhibitors,Angiotensin I-Converting Enzyme Inhibitors,Angiotensin-Converting Enzyme Antagonists,Antagonists, Angiotensin-Converting Enzyme,Antagonists, Kininase II,Inhibitors, ACE,Inhibitors, Angiotensin-Converting Enzyme,Inhibitors, Kininase II,Kininase II Antagonists,Angiotensin Converting Enzyme Antagonists,Angiotensin Converting Enzyme Inhibitors,Angiotensin I Converting Enzyme Inhibitor,Angiotensin I Converting Enzyme Inhibitors,Antagonists, Angiotensin Converting Enzyme,Enzyme Antagonists, Angiotensin-Converting,Enzyme Inhibitor, Angiotensin-Converting,Enzyme Inhibitors, Angiotensin-Converting,II Inhibitor, Kininase,Inhibitor, ACE,Inhibitor, Angiotensin-Converting Enzyme,Inhibitor, Kininase II,Inhibitors, Angiotensin Converting Enzyme
D058186 Acute Kidney Injury Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. Acute Kidney Failure,Acute Kidney Insufficiency,Acute Renal Failure,Acute Renal Injury,Acute Renal Insufficiency,Kidney Failure, Acute,Kidney Insufficiency, Acute,Renal Failure, Acute,Renal Insufficiency, Acute,Acute Kidney Failures,Acute Kidney Injuries,Acute Kidney Insufficiencies,Acute Renal Failures,Acute Renal Injuries,Acute Renal Insufficiencies,Kidney Failures, Acute,Kidney Injuries, Acute,Kidney Injury, Acute,Kidney Insufficiencies, Acute,Renal Failures, Acute,Renal Injuries, Acute,Renal Injury, Acute,Renal Insufficiencies, Acute

Related Publications

M A Schalekamp, and G J Wenting
Angiotensin converting enzyme inhibition in renovascular hypertension: frequency of reversible renal failure.
January 1984, Lancet (London, England),
M A Schalekamp, and G J Wenting
Effect of angiotensin converting enzyme inhibition in renovascular hypertension.
September 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
M A Schalekamp, and G J Wenting
Differential renal function during angiotensin converting enzyme inhibition in renovascular hypertension.
August 1986, Hypertension (Dallas, Tex. : 1979),
M A Schalekamp, and G J Wenting
Angiotensin-converting enzyme inhibition and renovascular disease.
October 1990, The Quarterly journal of medicine,
M A Schalekamp, and G J Wenting
Angiotensin converting enzyme inhibition improves diagnostic procedures for renovascular hypertension in dogs.
October 1988, Hypertension (Dallas, Tex. : 1979),
M A Schalekamp, and G J Wenting
Renographic diagnosis of renovascular hypertension with angiotensin converting enzyme inhibition and furosemide.
December 1991, American journal of hypertension,
M A Schalekamp, and G J Wenting
Enhancement of screening tests for renovascular hypertension by angiotensin-converting enzyme inhibition.
January 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M A Schalekamp, and G J Wenting
Angiotensin-converting enzyme inhibition in renovascular hypertension: the narrowing gap between functional renal failure and progressive renal atrophy.
January 1990, The Journal of laboratory and clinical medicine,
M A Schalekamp, and G J Wenting
Angiotensin converting enzyme inhibition in hypertension.
August 1987, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
M A Schalekamp, and G J Wenting
Diagnostic uses of angiotensin-converting enzyme inhibitors in renovascular hypertension.
October 1988, American journal of hypertension,
Copied contents to your clipboard!